Project Details
Description
The objective is to develop a preclinical program that will inform clinical trial design that we anticipate will have several benefits in treatment of patients with metastatic CRC.
| Status | Active |
|---|---|
| Effective start/end date | 18/08/22 → 17/08/25 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.